Gan to kagaku ryoho. Cancer & chemotherapy · 2024
[Our Experience of Staging Laparoscopy for Patients with Pancreatic Cancer before Initial Treatment].
Аннотация на английскомСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Iwado Masaki, Matsukuma Satoshi, Amano Shogo, Senyo Manabu, Nishio Yusuke, Yamatani Hiroaki, Haraguchi Daiki, Suzuki Atomu, Yamamoto Naohiro, Yoshimine Sota, Tokuno Kazuhisa, Kawaoka Toru, Fujita Yuji, Akiyama Norio, Yamamoto Shigeru
Аннотация
BACKGROUND: Staging laparoscopy(SL)for patients with pancreatic cancer is used to identify occult abdominal metastasis (OAM). The aim of this study is to analyze the efficacy and safety of SL.
METHODS: Patients with pancreatic cancer who underwent SL before initial treatment at our hospital were included in this study. The short-term outcomes of the patients and the frequency of OAM detection were retrospectively analyzed.
RESULTS: Ten patients with pancreatic cancer were enrolled. The tumors were located in the head of the pancreas in 5 cases, and in the body and/or tail in 5 cases. The tumor diameter was 3 cm or more in 2 cases, and the serum CA19-9 level was 150 U/mL or more in 7 cases. No postoperative complications were observed in any of the patients. SL showed OAM in 2 patients.
CONCLUSIONS: SL can be performed safely and may be useful in detecting OAM and optimizing treatment strategy for pancreatic cancer patients.
METHODS: Patients with pancreatic cancer who underwent SL before initial treatment at our hospital were included in this study. The short-term outcomes of the patients and the frequency of OAM detection were retrospectively analyzed.
RESULTS: Ten patients with pancreatic cancer were enrolled. The tumors were located in the head of the pancreas in 5 cases, and in the body and/or tail in 5 cases. The tumor diameter was 3 cm or more in 2 cases, and the serum CA19-9 level was 150 U/mL or more in 7 cases. No postoperative complications were observed in any of the patients. SL showed OAM in 2 patients.
CONCLUSIONS: SL can be performed safely and may be useful in detecting OAM and optimizing treatment strategy for pancreatic cancer patients.